◆ NeutralGEHC

Bragar Eagel & Squire, P.C. Continues Investigating GE HealthCare Technologies Inc. on Behalf of GE HealthCare Stockholders and Encourages Investors to Contact the Firm

GlobeNewswire Inc.·
Bragar Eagel & Squire, P.C. Continues Investigating GE HealthCare Technologies Inc. on Behalf of GE HealthCare Stockholders and Encourages Investors to Contact the Firm

Law firm Bragar Eagel & Squire is investigating GE HealthCare Technologies for potential securities law violations following the company's April 29, 2026 earnings announcement. GE HealthCare missed consensus EPS estimates ($0.99 vs. $1.05 expected) and reduced full-year 2026 guidance, citing a PDx supplier issue. The stock fell 13% ($9.01 per share) on the news. The firm is seeking investors who suffered losses to join the investigation.

Read Full Article at GlobeNewswire Inc.
← Back to Financial Intelligence